Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells-Reference-Cited by-同舟云学术

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells

Published:2017-07-19 Issue:35 Volume:8 Page:58847-58864
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhao Ming¹,Howard Erin W.¹,Parris Amanda B.¹,Guo Zhiying¹,Zhao Qingxia¹²,Ma Zhikun¹,Xing Ying²,Liu Bolin³,Edgerton Susan M.³,Thor Ann D.³,Yang Xiaohe¹⁴

Affiliation:

1. Julius L. Chambers Biomedical/Biotechnology Research Institute and Department of Biological and Biomedical Sciences, North Carolina Central University, Kannapolis, North Carolina, USA

2. Basic Medical College of Zhengzhou University, Zhengzhou, Henan, P.R. China

3. Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

4. College of Medicine, Henan University of Sciences and Technology, Luoyang, Henan, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P ₁ signaling axis;Science Signaling;2023-08-15

2. CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer;Journal of Clinical Medicine;2022-03-14

3. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy;PHARMACOL RES;2020

4. Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer – A comprehensive review from chemotherapy to immunotherapy;Pharmacological Research;2020-06

5. Contribution Value of Akt, c-Myc, CIP2A, and PP2A Genes Expression in Leukemogenesis: A Bright Perspective on the Molecular Pattern of Patients with Acute Myeloid Leukemia (AML);International Journal of Cancer Management;2020-03-10